Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Trientin (ATC-Code nach WHO: A16AX12)

The subject of this publication is the conclusion of non-exclusive discount agreements under Section 130a, paragraph 8, SGB V for medicinal products containing the active substance Trientin (ATC Code according to WHO: A16AX12). The contract is concluded within the framework of an "Open-House" model, i.e. a contract conclusion is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. It is noted that the quantity to be procured is unknown, as it depends on demand and the development of the number of insured persons, the prescribing behavior of doctors, and the dispensing and stocking behavior of public pharmacies. Minimum procurement quantities are therefore not guaranteed. Interested pharmaceutical companies can download the participation documents from the project room of the German Tender Portal (DTVP). An application for access to the project room is required. After the applicant has been granted access by the contracting entity, the participation documents can be accessed. Absolute confidentiality must be maintained regarding the content of the participation documents - in particular regarding the content of the discount agreement and the discounts mentioned therein. Any full or partial disclosure or provision of content from the participation documents to or for third parties requires the prior written consent of the contracting entity. If participation is waived, all documents must be destroyed immediately in accordance with data protection regulations. The documents to be submitted are listed in the documents "Cover Letter" and "Explanation of Contract Terms" stored in the project room. Communication, including the transmission of the participation documents, is conducted electronically via the tender portal DTVP; details can be found in the aforementioned documents. Any contrary information in the contract notice is due to technical reasons and is not binding. Participation applications can be submitted for the first time by 3 September 2026. All further submission deadlines can be found in the attachment "Submission Deadlines" stored in the project room. If the deadline for submission falls on a Saturday, Sunday or a public holiday nationwide, the next working day shall take its place. In the event of late receipt, the submitted participation applications will be considered for the next submission deadline. The discount agreement ends, regardless of the date of contract conclusion, by 30 September 2028 at the latest. The contracting entity reserves the right to terminate the Open-House procedure prematurely, in particular in the event of the conclusion of exclusive discount agreements; in this case, the already concluded discount agreements will end in accordance with the contractual provisions. According to the contracting entity's experience, exclusive discount agreements generally come into force 8 to 12 months after the publication of the corresponding contract notice in the Supplement to the Official Journal of the European Union.